Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)
China · Delayed Price · Currency is CNY 25.19
-0.18 (-0.71%)
At close: Feb 6, 2026
Yifeng Pharmacy Chain Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 1,643 | 1,529 | 1,412 | 1,262 | 887.88 | 743.52 |
Depreciation & Amortization | 1,860 | 1,860 | 1,649 | 1,441 | 1,191 | 941.94 |
Other Amortization | 287.14 | 287.14 | 182.97 | 145.38 | 117.19 | 97.32 |
Loss (Gain) From Sale of Assets | -46.1 | -46.1 | -29.09 | -12.84 | -6.85 | -0.32 |
Asset Writedown & Restructuring Costs | 18.83 | 18.83 | - | - | 1.43 | 1.58 |
Loss (Gain) From Sale of Investments | -108.13 | -108.13 | -42.37 | -6.87 | -34.37 | -29.42 |
Provision & Write-off of Bad Debts | -2.15 | -2.15 | 4.54 | 10.47 | 4.41 | 6.32 |
Other Operating Activities | -806.69 | 381.92 | 402.11 | 382.81 | 313.34 | 318.25 |
Change in Accounts Receivable | -554.45 | -554.45 | -258.28 | -1,013 | -600.7 | -275.83 |
Change in Inventory | -790.97 | -790.97 | -261.54 | -459.39 | -885.07 | -342.08 |
Change in Accounts Payable | 1,593 | 1,593 | 1,543 | 2,140 | 1,177 | 851.31 |
Change in Other Net Operating Assets | 65.42 | 65.42 | 42.4 | 23.16 | 19.27 | 38.45 |
Operating Cash Flow | 3,147 | 4,221 | 4,624 | 3,920 | 2,150 | 2,330 |
Operating Cash Flow Growth | -38.10% | -8.71% | 17.95% | 82.34% | -7.71% | 141.86% |
Capital Expenditures | -470.99 | -682.67 | -739.92 | -587.51 | -827.54 | -582.8 |
Sale of Property, Plant & Equipment | 67.22 | 66.27 | 15.78 | 9.03 | 6.52 | 3.88 |
Cash Acquisitions | -159.38 | -254.66 | -498.82 | -450.56 | -408.88 | -138.93 |
Divestitures | 1.2 | - | - | - | - | - |
Investment in Securities | -2,379 | -2,811 | -1,781 | -250.05 | 632 | -531.02 |
Other Investing Activities | 2,639 | 73.51 | 23.91 | 5.08 | 31.06 | -6.67 |
Investing Cash Flow | -301.63 | -3,609 | -2,980 | -1,274 | -566.84 | -1,256 |
Long-Term Debt Issued | - | 1,814 | - | 80 | 142.12 | 1,948 |
Long-Term Debt Repaid | - | -1,780 | -1,687 | -1,483 | -2,083 | -1,082 |
Net Debt Issued (Repaid) | -1,771 | 33.55 | -1,687 | -1,403 | -1,940 | 865.5 |
Issuance of Common Stock | - | - | 7.39 | 77.41 | - | 23.83 |
Repurchase of Common Stock | -4 | -4 | -3.52 | -2.85 | -1.69 | -2.22 |
Common Dividends Paid | -1,188 | -846.54 | -321.88 | -235.02 | -211.89 | -164.04 |
Other Financing Activities | 58.09 | -103.21 | -87.91 | -91.56 | -30.96 | -9.27 |
Financing Cash Flow | -2,905 | -920.2 | -2,093 | -1,655 | -2,185 | 713.8 |
Net Cash Flow | -60.24 | -307.78 | -449.62 | 991 | -601.88 | 1,788 |
Free Cash Flow | 2,676 | 3,539 | 3,884 | 3,333 | 1,322 | 1,747 |
Free Cash Flow Growth | -37.59% | -8.89% | 16.53% | 152.02% | -24.30% | 246.63% |
Free Cash Flow Margin | 11.09% | 14.71% | 17.19% | 16.76% | 8.63% | 13.29% |
Free Cash Flow Per Share | 2.13 | 2.87 | 3.22 | 2.75 | 1.10 | 1.51 |
Cash Income Tax Paid | 1,280 | 1,328 | 1,308 | 1,053 | 746.51 | 771.37 |
Levered Free Cash Flow | 1,418 | 3,213 | 3,203 | 3,123 | 1,096 | 1,934 |
Unlevered Free Cash Flow | 1,546 | 3,351 | 3,304 | 3,226 | 1,201 | 2,050 |
Change in Working Capital | 300.79 | 300.79 | 1,045 | 698.37 | -324.56 | 250.46 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.